Vertex, Mammoth partner to develop in vivo gene-editing therapies
Vertex Pharmaceuticals has collaborated with Mammoth Biosciences to develop in vivo gene-editing therapies for two genetic diseases. As part of the partnership, the companies will use Mammoth’s next-generation